The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 343:1260-1262 October 26, 2000 Number 17
NextNext

Non–Small-Cell Lung Cancer — Stalemate or Progress?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Lung cancer is a major health problem, and each year the overall rate of death from this tobacco-inflicted disease increases. In a few countries, including the United States, the death rate has decreased slightly, reflecting changing attitudes toward cigarette smoking.

Non–small-cell lung cancer, which includes adenocarcinoma, squamous-cell carcinoma, and large-cell carcinoma, accounts for 75 to 80 percent of all new cases of lung cancer; the remainder are due to small-cell lung cancer. In patients with non–small-cell lung cancer, the possibility of cure depends mainly on their suitability for surgical resection. Unfortunately, at the time of diagnosis, only about 30 percent . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.